Filter
Period
Filter by
recent search
Showing: 1 – 05 of 125 Regulated Information
–
14 November 2023
14 November 2023
–
13 November 2023
13 November 2023
Results from Ipsen’s ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England Journal of Medicine
PARIS, FRANCE, 13 November, 2023 – Ipsen (Euronext: IPN; ADR: IPSEY) and GENFIT (Nasdaq and Euronext: GNFT) today announced full results from the pivotal Phase III ELATIVE® trial, which are being presented in a late-breaking oral session (Abstract #484, Monday,…
–
07 November 2023
07 November 2023
–
06 November 2023
06 November 2023
Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares composing the share capital
–
31 October 2023
31 October 2023